Quality by design approach to optimize the formulation variables influencing the characteristics of biodegradable intramuscular in-situ gel loaded with alendronate sodium for osteoporosis
Autor: | Waleed Yousof Rizg, Khaled M. Hosny |
---|---|
Rok vydání: | 2018 |
Předmět: |
Polymers
Chemistry Pharmaceutical lcsh:Medicine 02 engineering and technology Physical Chemistry 030226 pharmacology & pharmacy chemistry.chemical_compound 0302 clinical medicine Pulmonary surfactant Materials Physics Medicine and Health Sciences lcsh:Science Connective Tissue Diseases Routes of Administration Drug Carriers Multidisciplinary Alendronate Viscosity Pharmaceutics Chemistry Physics Experimental Design 021001 nanoscience & nanotechnology Controlled release Macromolecules Research Design Physical Sciences Polycaprolactone Drug delivery Rabbits 0210 nano-technology Research Article Drug Administration Materials by Structure Polyesters Materials Science Biological Availability Research and Analysis Methods 03 medical and health sciences Rheumatology Drug Therapy Pharmacokinetics Animals Humans Intramuscular Injections Pharmacology Chromatography lcsh:R Biodegradation Polymer Chemistry Rats Bioavailability Alendronate Sodium Chemical Properties Delayed-Action Preparations Osteoporosis lcsh:Q Drug Delivery Gels |
Zdroj: | PLoS ONE PLoS ONE, Vol 13, Iss 6, p e0197540 (2018) |
ISSN: | 1932-6203 |
DOI: | 10.1371/journal.pone.0197540 |
Popis: | There are many challenges facing the use of alendronate sodium for the treatment of osteoporosis such as low bioavailability of 0.6% and oesophageal ulceration with bleeding. Due to the aforementioned limitation, the main objective of this research is to utilize a statistical experimental design in the formulation and optimization of alendronate in the form of controlled release biodegradable intramuscular in-situ gel. A Box-Behnken experimental design employing Statgraphics® software was used to develop an optimized in-situ gel formulation and to estimate the effects of Poly-DL-lactide-coglycolide as a primary polymer, the copolymer polycaprolactone, and lipid surfactant capryol 90. Every system was evaluated for gellation character, and in vitro release. As a novel technique for evaluation of the in-situ gel, in-vivo biodegradability rate was estimated in rats. Pharmacokinetic parameters were assessed in rabbits. The results indicated a significant effect of the copolymer and lipid surfactant on initial burst, and a significant effect of the primary and copolymer on drug percentage released. The optimum formulation showed a 5% initial burst, an in-vivo biodegradability rate estimated at 8% every seven days in rats, and the pharmacokinetic evaluation revealed that alendronate sodium mean residence time extended to 102 days in rabbits. In conclusion, the optimum biodegradable intramuscular in-situ gel formulations is a promising approach for providing higher bioavailability, extended release for more than three months, with elimination of esophageal side effects. |
Databáze: | OpenAIRE |
Externí odkaz: |